All articles by Praveen Duddu

  1. Report: Singapore’s pharmaceutical market to witness 5% CAGR up to 2021

    Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.15bn in 2021 in value, representing a compound…
    Read More…

    24 Nov
  2. M&As this week: Caligor Rx, Zhejiang Jolly Pharmaceutical

    US-based pharmacy Caligor Rx has taken over clinical trial material management services provider The Coghlan Group for an undisclosed sum. Caligor…
    Read More…

    24 Nov
  3. Report: Venezuela’s economic crisis to hit domestic pharmaceutical market

    Economic and political turmoil in Venezuela is anticipated to affect the growth rate of the domestic pharmaceutical market, according to…
    Read More…

    17 Nov
  4. M&As this week: Egyptian American Enterprise Fund, Valeant Pharmaceuticals International

    US-based private equity firm Egyptian American Enterprise Fund (EAEF) has acquired 46.5% stake in Egyptian ophthalmic pharmaceutical products developer Orchidia…
    Read More…

    10 Nov
  5. Deals this week: Sarepta Therapeutics, Cumberland Pharmaceuticals, CTI BioPharma

    Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes. Due 15 November 2024, the notes…
    Read More…

    10 Nov
  6. M&As this week: Northwind Pharmaceuticals, Anhui Anke Biotechnology

    US-based pharmaceutical company Northwind Pharmaceuticals has acquired pharmaceutical company Denton Pharma, also based in the US. The acquirer company aims to…
    Read More…

    27 Oct
  7. Deals this week: Alimera Sciences, ThromboGenics, AbbVie

    Alimera Sciences plans to raise $100m in a public offering of securities including common stock, preferred stock, debt securities, warrants and…
    Read More…

    27 Oct
  8. Report: Global migraine market forecast to reach $8.7bn by 2026

    The global migraine market is expected to witness a compound annual growth rate (CAGR) of 10.3% up to 2026, according…
    Read More…

    29 Sep
  9. Report: Multiple pipeline products to drive growth of healthcare-associated infections market

    The global healthcare-associated infections (HAIs) market is expected to witness a compound annual growth rate (CAGR) of 10.8% between 2016…
    Read More…

    21 Sep
  10. Report: Sepsis and septic shock treatment to be $5.9bn market by 2026

    The market for sepsis and septic shock across the seven major pharmaceutical markets of the US, France, Germany, Italy, Spain,…
    Read More…

    14 Sep
Close
Close
Close

Go Top